Executive Director responsible for global market access strategies at SpringWorks Therapeutics. Leading initiatives and aligning value propositions across international markets with emphasis on rare diseases.
Responsibilities
Lead the development of global market access strategies that support regional execution and reflect local payer and policy environments
Provide strategic oversight and guidance on HEOR frameworks and evidence generation to support value demonstration and HTA readiness
Monitor and interpret global policy developments and assess their implications for pricing, reimbursement, and access strategy
Collaborate cross-functionally with Medical Affairs, Regulatory, and Commercial teams to ensure alignment of value messaging and evidence plans
Advise regional market access teams on stakeholder engagement strategies, including communication of product value to payers, healthcare executives, and population health decision-makers
Ensure global value propositions are adaptable and relevant across diverse healthcare systems and reimbursement models
Serve as a strategic thought partner to regional leaders, offering insight and support throughout the product lifecycle
Interface with external reimbursement stakeholders across international markets, including:
Regional payers and health authorities
Health technology assessment (HTA) bodies
Specialty distributors and third-party vendors
Population-based decision-makers and policy influencers
Lead strategic planning and oversight of:
Launch readiness activities for OUS markets
Milestone tracking and performance measurement
Post-launch execution and access optimization
Collaborate cross-functionally across the organization, including:
Regional field access and commercial teams
Global medical affairs, regulatory, and HEOR functions
Internal stakeholders to ensure alignment of value messaging and evidence strategy
Monitor and interpret global policy developments, including:
Most Favored Nation (MFN) pricing rules
International reference pricing frameworks
Emerging legislation impacting reimbursement in major ex-US markets
Provide strategic guidance (not operational ownership) on:
HEOR frameworks and evidence generation plans
HTA submission readiness and value demonstration strategies
Ensure global value propositions are locally adaptable and relevant across diverse healthcare systems
Perform other duties and responsibilities as assigned
Requirements
Bachelor’s Degree required
10-12 years of pharmaceutical and/or biotech experience required in rare disease or Oncology with a Bachelor’s degree; 10 years of experience with a Master’s degree or 6 years of experience with a PhD
5+ years in internal Market access role
5+ years of people leadership experience
Launch experience required
Pricing experience preferred
Field experience preferred
Marketing experience preferred
Experience in patient administered products (Part D, oral)
Experience working in a collaborative, dynamic, accountable environment
Expert in Global Market Access environment with deep knowledge of recent policy changes, external product launches and current dynamics in Rare & Oncology
Inclusive, people first leader with demonstrated examples of successful collaboration and engagement in a fast-moving environment
Strong communication both written and verbal
Collaborative and curious by nature
Ability to travel occasionally including overnight stay driven by business need.
This position must be able to work East Coast hours.
Benefits
Best-in-class benefits for our team
Discretionary annual bonus based on individual and Company performance
Job title
Executive Director, Global Value, Access & Pricing
Director, Labelling Strategy & Development overseeing global labelling for therapeutic areas at GSK. Leading labelling governance and compliance with regulatory requirements.
Director of Oncology Clinical Pharmacology at GSK focusing on modeling and simulation. Drives development strategies and collaborates on innovative oncology therapies to improve patient outcomes.
Director Biostatistics at Bristol Myers Squibb driving innovative clinical trial designs. Leading statistical support and ensuring compliance within regulatory frameworks.
Associate Director of Biostatistics at Bristol Myers Squibb responsible for trial design and statistical analysis. Collaborating with teams to manage studies and ensure adherence to standards.
Director of eCOA Management overseeing operationalization of eCOA for clinical trials at BMS. Leading a global team to ensure quality and compliance across studies.
Regional Director managing advisor relationships for Voya Financial. Providing strategic input and fostering advisor success through support and collaboration across internal teams.
Director of Compensation Programs at Unum developing global compensation structure. Managing analytics and strategic insights to drive employee career growth and business objectives.
Director defining and leading advanced packaging and 3DIC implementation flows for Cadence. Collaborating with R&D and product engineering teams, potential management responsibilities as team grows.
Director of Health Economics leading HEOR strategy for Integra’s medical technologies. Providing economic insights to support market access and competitive differentiation.
Development Director leading fundraising efforts for Repair the World in San Francisco Bay Area and Chicago communities. Managing donor relationships and implementing local fundraising strategies.